Search Results 61-70 of 16449 for crohns%20disease

  1. Improving the Quality of Care for Adults with Inflammatory Bowel Disease - Mayo Clinic

    The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients and ...

  2. A Study to Analyze AVB-114 to Treat Complex Crohn’s Perianal Fistulas in Subjects with Quiescent Rectal Disease - Mayo Clinic

    It also aims to assess clinical and radiologic components of fistula remission, safety of treatment, disease activity, patient Quality of Life, and patient care ...

  3. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult ...

  4. Hirschsprung's disease - Symptoms & causes - Mayo Clinic

    Hirschsprung's (HIRSH-sproongz) disease is a condition that affects the large intestine (colon) and causes problems with passing stool.

  5. Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease - Mayo Clinic

    The purpose of this study is to determine if taking an increased sampling of mesentery (fatty tissue next to the intestine) and lymph nodes at the time of the ...

  6. Ulcerative colitis - Diagnosis and treatment - Mayo Clinic

    This type of inflammatory bowel disease affects the innermost lining of your digestive tract. Learn about available treatments for this often exhausting ...

  7. Sharing Mayo Clinic: Lifting the weight of debilitating inflammatory bowel disease

    Ulcerative colitis and Crohn's disease are the two main types. Marissa began experiencing symptoms of inflammatory bowel disease when she was in her early 20s.

  8. Pediatric MSC-AFP Sub-study for Crohn's Fistula - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study to Evaluate the Effectiveness and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation - Mayo Clinic

    The purpose of this study is to evaluate the effects, safety and how OPS-2071 (150, 300, or 600 mg twice a day [BID]) is as an add-on therapy in Crohn's disease ...

  10. A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Moderate-to-Severe, Active Crohn's Disease - Mayo Clinic

    A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Moderate-to-Severe, Active Crohn's Disease · Overview.